Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT01916785
PHASE2

OPTIM DASATINIB (Optimized Tyrosine Kinase Inhibitors Monotherapy)

Sponsor: Versailles Hospital

View on ClinicalTrials.gov

Summary

This protocol is a multicentric interventional phase II study from the French CML Intergroup (FILMC). The core of the protocol is to explore the efficacy and safety of an optimization strategy consisting in the modulation of the dasatinib daily dose according to the results of repeated plasmatic levels of dasatinib. The objective of this strategy is to improve the overall results of the treatment of early CP-CML in order to avoid the development of resistance and BCR-ABL tyrosine kinase mutations. The study will be conducted in selected FILMC and Canadian centers. The study is sponsored by the Hôpitaux de Versailles and supported by Bristol-Myers Squibb. The dasatinib treatment will be provided by Bristol-Myers Squibb until marketing authorization is granted in that indication.

Official title: A PROSPECTIVE RANDOMIZED PHASE II STUDY EVALUATING THE OPTIMIZATION OF THE RESIDUAL PLASMATIC LEVEL OF DASATINIB (SPRYCEL®) IN PATIENTS NEWLY DIAGNOSED WITH CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

289

Start Date

2009-05

Completion Date

2013-12

Last Updated

2026-07-06

Healthy Volunteers

No

Interventions

DRUG

Dasatinib

Dasatinib is a multitargeted tyrosine kinase inhibitor with a 300-fold more potent activity on the BCR-ABL tyrosine kinase in vitro compared to imatinib mesylate

Locations (34)

Southern Alberta Cancer Research Institute

Calgary, Canada

Hôpital Charles LeMoyne

Greenfield Park, Canada

Queen elisabeth II Health Sciences Center

Halifax, Canada

CH Pierre LeGardeur

Lachenaie, Canada

Moncton City Hospital

Moncton, Canada

Hôpital Général Juif - Sir. Mortimer B. Davis

Montreal, Canada

Hôpital Maisonneuve-Rosemont

Montreal, Canada

Hôpital Royal Victoria

Montreal, Canada

Hôpital de l'Enfant Jésus - Centre hospitalier affilié universitaire de Québec

Québec, Canada

Pavillon Hôtel-Dieu de Québec - Centre hospitalier universitaire de Québec

Québec, Canada

CHU Angers

Angers, France

Hôpital Avicenne

Bobigny, France

Institut Bergonie

Bordeaux, France

Hopital MORVAN

Brest, France

CH René Dubos

Cergy-Pontoise, France

Hôpital d'Instruction de Armées Percy

Clamart, France

Hopital Henri MONDOR

Créteil, France

Hôpital Claude Huriez

Lille, France

CH Lyon Sud

Lyon, France

Institut Paoli-Calmettes

Marseille, France

Hôpital d'Annecy

Metz-Tessy, France

C.H.U. Brabois

Nancy, France

CHU Hoptel dieu

Nantes, France

Hôpital l'Archet 1

Nice, France

CHU Caremeau

Nîmes, France

Hopital Saint Louis

Paris, France

Hôpital Necker-Enfants Malades

Paris, France

Hôpital St Antoine

Paris, France

CHU Poitiers

Poitiers, France

CHU Rennes - Pontchaillou

Rennes, France

Centre René Huguenin

Saint-Cloud, France

Hôpital Purpan

Toulouse, France

CHRU Bretonneau

Tours, France

Central Hospital

Versailles, France